Belgium
# |
Name |
Revenue |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 264.60 M
|
Dec. 31, 2023 | USD 22.80 | -1.44% |
|
Belgium |
The Vaccines company in Belgium with the highest Revenue is Galapagos NV (Amsterdam Stock Exchange: GLPG.AS) at USD 264.60 M.
The Vaccines company in Belgium with the lowest Revenue is Galapagos NV (Amsterdam Stock Exchange: GLPG.AS) at USD 264.60 M.
The top 10 Vaccines companies in Belgium by Revenue are and Galapagos NV.
The bottom 10 Vaccines companies in Belgium by Revenue are and Galapagos NV.